Skip to main navigation

Science
Therapeutic Focus
About Us
Careers
Investors

LinkedIn
Terms of Service
Careers

Contact

1545 Park Avenue
Emeryville, California 94608

info@metagenomi.co

News Releases

Investor Menu

Investor Relations

Most Recent Information
News & Events
Stock Information
- Stock Quote & Chart
- Historic Price Lookup
Corporate Governance
Financials & Filings
- SEC Filings
IR Resources

Year

News Releases

09.03.24

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

News Releases

08.29.24

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

News Releases

08.28.24

Metagenomi to Participate in Upcoming Investor Conferences

News Releases

08.14.24

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

News Releases

05.29.24

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

News Releases

05.14.24

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

News Releases

05.01.24

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

News Releases

04.08.24

Metagenomi to Present at Upcoming Scientific Meetings

News Releases

03.27.24

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

News Releases

02.29.24

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 12

WHAT WE DO

Gene Editing Toolbox
Therapeutic Focus
Discovery Platform

NEWS

News Index
Press Releases
In The News
Posters & Publications

COMPANY

About Us

Contact

1545 Park Avenue
Emeryville, California 94608

info@metagenomi.co

Headquarters

5959 Horton St, Floor 7
Emeryville, California 94608

LinkedIn
Terms of Service
Careers